Laser immunotherapy for metastatic pancreatic cancer (Conference Presentation)

Feifan Zhou

doi:10.1117/12.2250212

19 April 2017 Laser immunotherapy for metastatic pancreatic cancer (Conference Presentation)

Feifan Zhou

Proceedings Volume 10065, Biophotonics and Immune Responses XII; 1006508 (2017) https://doi.org/10.1117/12.2250212
Event: SPIE BiOS, 2017, San Francisco, California, United States

Abstract

Pancreatic cancer is an extremely malignant disease with high mortality rate. Currently there is no effective therapeutic strategy for highly metastatic pancreatic cancers. Laser immunotherapy (LIT) is a combination therapeutic approach of targeted phototherapy and immunotherapy, which could destroy treated primary tumors with elimination of untreated metastases. LIT affords a remarkable efficacy in suppressing tumor growth in pancreatic tumors in mice, and results in complete tumor regression in many cases. LIT could synergize targeted phototherapy and immunological effects of immunoadjuvant, which represent a promising treatment modality to induce systemic antitumor response through a local intervention, paving the way for the treatment of highly metastatic pancreatic cancers.

Conference Presentation

Citation Download Citation

Feifan Zhou "Laser immunotherapy for metastatic pancreatic cancer (Conference Presentation)", Proc. SPIE 10065, Biophotonics and Immune Responses XII, 1006508 (19 April 2017); https://doi.org/10.1117/12.2250212

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available